Meeder Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68K | Buy |
+62
| New | +$2.68K | ﹤0.01% | 791 |
|
|
2024
Q2 | – | Sell |
-82
| Closed | -$2.54K | – | 865 |
|
|
2024
Q1 | $2.54K | Buy |
+82
| New | +$2.54K | ﹤0.01% | 705 |
|
|
2021
Q4 | – | Sell |
-2,034
| Closed | -$95K | – | 1272 |
|
|
2021
Q3 | $95K | Buy |
2,034
+649
| +47% | +$30.3K | 0.01% | 908 |
|
|
2021
Q2 | $84K | Sell |
1,385
-1,630
| -54% | -$98.9K | ﹤0.01% | 953 |
|
|
2021
Q1 | $185K | Buy |
+3,015
| New | +$185K | 0.01% | 746 |
|
|
2020
Q4 | – | Sell |
-2,052
| Closed | -$77K | – | 1886 |
|
|
2020
Q3 | $77K | Buy |
2,052
+356
| +21% | +$13.4K | 0.01% | 850 |
|
|
2020
Q2 | $57K | Buy |
1,696
+1,643
| +3,100% | +$55.2K | ﹤0.01% | 896 |
|
|
2020
Q1 | $2K | Buy |
+53
| New | +$2K | ﹤0.01% | 2058 |
|